SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ONXX

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (284)4/12/1999 2:11:00 AM
From: scaram(o)uche  Read Replies (1) of 810
 
schedule of some presentations......

"Generation of tumor-selective, replication competent adenoviruses."

Schedule:
Tue Apr 13
8:00AM - 12:00PM
Speaker(s): T. Hermiston ; C. Heise ; A. Sampson-Johannes ; D. Castro ; J. Holt ; G. Kitzes ; D. Kirn

"Increased antitumor efficacy using combination therapy with
ONYX-015, a selectively-replicating adenovirus, and chemotherapy in vitro and in vivo."
Schedule:
Wed Apr 14
7:30AM - 11:30AM
Speaker(s): C. Heise ; T. Hermiston ; A. Sampson- Johannes ; G. Brooks ; S. Xue ; P. Trown ; D. Kirn

"Replicating adenoviral gene delivery."
Schedule:
Tue Apr 13
8:00AM - 12:00PM
Speaker(s): L. Hawkins ; J. Nye ; D. Castro ; L. Johnson ; C. Heise ; A. Sampson-Johannes ; D. Kirn ; T. Hermiston

"A novel approach for the identification of PAX3-FKHR target genes."
Schedule:
Mon Apr 12
1:00PM - 5:00PM
Speaker(s): J. Khan ; K. Ayyanathan ; P. S. Meltzer ; W. J. Fredericks ; F. J., III Rauscher



Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext